• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hologic offers up to $85m for SuperSonic Imagine

Hologic offers up to $85m for SuperSonic Imagine

June 21, 2019 By Brad Perriello

Hologic acquires SuperSonic ImagineHologic (NSDQ:HOLX) and SuperSonic Imagine (EPA:SSI) yesterday revealed a binding offer that would see Hologic pay some $85 million to acquire the French ultrasound device maker.

Marlborough, Mass.-based Hologic’s €1.50-per-share bid amounts to about $42 million for all outstanding SSI shares and warrants, plus not more than $43 million to pay off any debts owed by Aix-en-Provence-based SuperSonic Imagine. The offering price is a 42.9% premium on SSI’s €YY closing price June 19 and a 45.7% premium on the stock’s 60-day volume-weighted average price, the companies said.

SuperSonic Imagine posted sales of about $29 million last year, with less than 15% of that coming from the U.S., and employs about 180 workers. Its main shareholders have already pledged to sell their 46% stake to Hologic; if that sale goes through Hologic would make a cash tender offer for the remaining shares. That offer is slated to close by the end of the year.

“Like our previous acquisitions of Faxitron and Focal, acquiring SuperSonic Imagine will strengthen our strategy to provide comprehensive screening, interventional and surgical solutions across the continuum of breast health care,” breast & skeletal health president Pete Valenti said in prepared remarks. “Ultrasound is becoming increasingly important in diagnosing breast cancer, and we believe SuperSonic Imagine offers superior technology that translates into better clinical outcomes for breast cancer patients, as well as for patients with liver and prostate disease.”

“SuperSonic Imagine’s objective is to give itself the means to accelerate its commercial growth, by continuing to invest in innovation and improving its operational excellence. To do so, we were looking for a partner who could not only support this development financially but also help us to penetrate new markets, particularly the U.S. market, more quickly and accompany us in the optimization of our processes in order to improve customer satisfaction,” added SuperSonic Imagine CEO Michèle Lesieur. “This contemplated acquisition of SuperSonic Imagine by Hologic meets all our strategic objectives, and would allow us to develop the ultrasound activity within a group that shares our values: The substantial importance of innovation, the contribution to improving healthcare, the added value of relationships with clinicians and the importance of the human factor within the companies. I am delighted with this opportunity for SuperSonic Imagine, because I firmly believe that it will allow us to write a new page in the history of this great company.”

Hologic estimated that the buyout would be less than 1% dilutive to its adjusted earnings per share for fiscal 2020.

($1 = €0.883355)

Filed Under: Featured, Imaging, Mergers & Acquisitions, Ultrasound, Wall Street Beat Tagged With: Hologic, SuperSonic Imagine S.A.

More recent news

  • Medtronic reports first patient treated in study of multi-organ denervation for hypertension
  • Baxter turns to an automation company for its new CEO
  • Pristine Surgical appoints new CFO
  • Boston Scientific wins expanded FDA nod for Farapulse PFA
  • FDA warns on issue with J&J Abiomed pump controllers related to 3 deaths

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy